| Gina M Lacapra, MD | |
|
3 Farrington St, Vauxhall, NJ 07088-1307 | |
| (973) 971-7185 | |
| Not Available |
| Full Name | Gina M Lacapra |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 33 Years |
| Location | 3 Farrington St, Vauxhall, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568475911 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA05815400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlook Medical Center | Summit, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
Nicholas Akerman's experience of working in Australia was that people are unable to work with patients without being screened and cleared. Yet, having worked in England in medicine for over 12 years, he has never once been screened. "Surely we should at least be adopting this policy to help combat the problem?" he asks.
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have just described for the first time the crucial involvement of a cell membrane protein in the development and progression of liver cancer, according to an article published in the Journal of Hepatology.
Today, leaders in healthcare, wellness, safety and fitness came together to launch the STOP Sports Injuries campaign. The campaign will educate athletes, parents, trainers, coaches and healthcare providers about the rapid increase in youth sports injuries, the necessary steps to help reverse the trend and the need to keep young athletes healthy.
Final results from PARAMOUNT, a Phase III study of ALIMTA (pemetrexed for injection) in the continuation maintenance setting, demonstrated improved overall survival in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) treated with ALIMTA continuation maintenance, according to data announced today by Eli Lilly and Company.
› Verified 5 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Nicholas Akerman's experience of working in Australia was that people are unable to work with patients without being screened and cleared. Yet, having worked in England in medicine for over 12 years, he has never once been screened. "Surely we should at least be adopting this policy to help combat the problem?" he asks.
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have just described for the first time the crucial involvement of a cell membrane protein in the development and progression of liver cancer, according to an article published in the Journal of Hepatology.
Today, leaders in healthcare, wellness, safety and fitness came together to launch the STOP Sports Injuries campaign. The campaign will educate athletes, parents, trainers, coaches and healthcare providers about the rapid increase in youth sports injuries, the necessary steps to help reverse the trend and the need to keep young athletes healthy.
Final results from PARAMOUNT, a Phase III study of ALIMTA (pemetrexed for injection) in the continuation maintenance setting, demonstrated improved overall survival in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) treated with ALIMTA continuation maintenance, according to data announced today by Eli Lilly and Company.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gina M Lacapra, MD Po Box 23831, Newark, NJ 07189-0001 Ph: (973) 971-7185 | Gina M Lacapra, MD 3 Farrington St, Vauxhall, NJ 07088-1307 Ph: (973) 971-7185 |
News Archive
Nicholas Akerman's experience of working in Australia was that people are unable to work with patients without being screened and cleared. Yet, having worked in England in medicine for over 12 years, he has never once been screened. "Surely we should at least be adopting this policy to help combat the problem?" he asks.
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have just described for the first time the crucial involvement of a cell membrane protein in the development and progression of liver cancer, according to an article published in the Journal of Hepatology.
Today, leaders in healthcare, wellness, safety and fitness came together to launch the STOP Sports Injuries campaign. The campaign will educate athletes, parents, trainers, coaches and healthcare providers about the rapid increase in youth sports injuries, the necessary steps to help reverse the trend and the need to keep young athletes healthy.
Final results from PARAMOUNT, a Phase III study of ALIMTA (pemetrexed for injection) in the continuation maintenance setting, demonstrated improved overall survival in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) treated with ALIMTA continuation maintenance, according to data announced today by Eli Lilly and Company.
› Verified 5 days ago
Dr. Wen Xiong, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2280 Springfield Ave, Vauxhall, NJ 07088 Phone: 908-688-1288 Fax: 908-688-1588 | |
Dr. Lisa Carabelli Hurckes, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3 Farrington St, Vauxhall, NJ 07088 Phone: 908-598-7950 Fax: 908-686-1163 | |
Dr. Mirela C Feurdean, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Farrington St, Vauxhall, NJ 07088 Phone: 908-598-7950 Fax: 908-686-1163 | |
Joseph Ballaro, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2933 Vauxhall Rd, Suite 28, Vauxhall, NJ 07088 Phone: 908-687-1520 Fax: 908-687-1989 |